Chronic myelogenous leukemia presenting with Morel Lavallée lesion: A case report of a rare presentation. [PDF]
Mohamed SSI +7 more
europepmc +1 more source
Fractal-fractional modeling of chronic myelogenous leukemia immune dynamics using Laguerre wavelets method. [PDF]
Khirsariya SR, Noori N.
europepmc +1 more source
Cannabidiol modulates exosomal miRNA networks to enhance Imatinib mesylate response in chronic myelogenous leukemia. [PDF]
Donchev PP +3 more
europepmc +1 more source
DNA self-assembly nanoflower reverse P-glycoprotein mediated drug resistance in chronic myelogenous leukemia therapy. [PDF]
Zhao P +8 more
europepmc +1 more source
Multimodal gene and targeted drug therapy for chronic myelogenous leukemia using BIM/MCL-1 chimeric nanoparticle: computational target analysis and therapeutic validation. [PDF]
Lugin ML +8 more
europepmc +1 more source
Effect of asciminib and vitamin K2 on Abelson tyrosine-kinase-inhibitor-resistant chronic myelogenous leukemia cells. [PDF]
Okabe S, Gotoh A.
europepmc +1 more source
Inhibition of autophagy enhances the sensitivity of ciclopirox olamine in human chronic myelogenous leukemia K562 cells. [PDF]
Zhou H, Chen H, Luo K, Kong L, Li Y.
europepmc +1 more source
Methyl-Thiol-Bridged Oxadiazole and Triazole Heterocycles as Inhibitors of NF-κB in Chronic Myelogenous Leukemia Cells. [PDF]
Basappa B +9 more
europepmc +1 more source
Impact of non-coding RNAs on resistance to imatinib in chronic myelogenous leukemia. [PDF]
Ensafi Talemi F, Ghafouri-Fard S.
europepmc +1 more source
Research on the functions and potential mechanisms of STAT3 in chronic myelogenous leukemia. [PDF]
Feng X, Qin Y, Feng Y, Zhuo Y.
europepmc +1 more source

